Search
for
Sort by
Research 541–570 of 1000+
- LabeledIn: Cataloging labeled indications for human drugs
- Vaniqa--eflornithine 13.9% cream.
- The Potential Role of Minoxidil in the Hair Transplantation Setting
- Incidence and management of cutaneous toxicities associated with cetuximab
- Review of the effects of 17α-estradiol in humans: a less feminizing estrogen with neuroprotective potential
- Alopecia: unapproved treatments or indications
- ADVANCES IN PSORIASIS THERAPY
- Neurosteroid influence on affective tone
- Parenteral Nutrition Trace Element Product Shortage Considerations
- Home-Use Laser and Light Devices for the Skin—An Update
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review
- Preparing regenerative therapies for clinical application: proposals for responsible translation
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- Topical bimatoprost for the treatment of eyebrow hypotrichosis.
- Evidence for supplemental treatments in androgenetic alopecia.
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Heterogeneity in amount of growth factors secreted by platelets in platelet‐rich plasma samples from alopecia patients
- Artificial Hair: By the Dawn to Automatic Biofibre® Hair Implant
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Cosmetics
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Aphalangia possibly linked to unintended use of finasteride during early pregnancy
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Is there a rationale for the use of botulinum toxin in the treatment of Androgenetic Alopecia?
- Response to: “Rethinking biotin therapy for hair, nail, and skin disorders”
- Update on Exosomes in Aesthetics
- Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know